Partial
Mostly Aligned
Patient Risk:
Low
Summary
The AI-generated claims largely align with the label for nitrates, hypersensitivity, GC stimulator interactions, alpha-blocker cautions, CYP3A4 inhibitors, and cardiovascular warnings. Several statements are accurate, while a few are unsupported or contradicted (notably NAION risk contraindication in retinitis pigmentosa) or absent (hepatic/renal ESRD specifics, grapefruit interactions, and some dosage/alternative-therapy details).
Category Scores
Accurate Statements
Contraindicated with nitrates or nitric oxide donors (e.g., nitroglycerin, isosorbide mononitrate, amyl nitrite).
4.1
Nitrate-containing combinations can cause severe hypotension due to vasodilation.
4.1, 5.1
Known hypersensitivity to sildenafil or any component is contraindicated.
4.2
Not for use after recent myocardial infarction within 6 months.
5.1
Not for use after stroke within 6 months.
5.1
Not for use in patients with severe hypotension (BP <90/50 mmHg).
5.1
Not for use in uncontrolled hypertension.
5.1
Avoid in those with severe cardiovascular disease, including unstable angina or heart failure symptoms.
5.1
Do not combine with guanylate cyclase stimulators like riociguat.
4.3
Riociguat can amplify hypotensive effects when combined with Viagra.
4.3
Alpha-blockers require caution when used with Viagra.
7.2
Protease inhibitors (e.g., ritonavir) and other CYP3A4 inhibitors require dose considerations to avoid toxicity.
7.4
Viagra's label emphasizes screening for cardiovascular risk before prescribing.
5.1
Unsupported Statements
Patients with severe hepatic impairment (Child-Pugh class C) or end-stage renal disease on dialysis should not take it.
Label does not state absolute contraindication for ESRD or Child-Pugh C; instead provides dose considerations.
Riociguat treats pulmonary hypertension.
Label discusses riociguat only as a GC stimulator; it does not state its indication within this Viagra label context.
Grapefruit juice can increase sildenafil levels.
Not described in the provided label sections.
Grapefruit juice can raise side effect risks.
Not described in the provided label sections.
Avoid large amounts of grapefruit juice.
Not described in the provided label sections.
Consult a doctor for alternatives like Cialis (tadalafil) or non-PDE5 options if contraindications apply.
Not described in the provided label sections.
Alpha-blockers require dose adjustments when used with Viagra.
Label mentions caution and starting dose but not explicit dose-adjustment guidance.
Alpha-blockers are not absolute contraindications if stabilized when used with Viagra.
Not described as such in label.
Contradictions
Low
AI Statement
Contraindicated in hereditary degenerative retinal disorders like retinitis pigmentosa due to NAION risk.
Label Reference
5.3
Important Omissions
Renal/hepatic impairment specifics and ESRD status as absolute contraindication are not stated; label provides dose adjustments rather than blanket contraindication.
Importance:
Moderate
Grapefruit-drug interactions are not described in the provided label sections.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Overall alignment with warnings/contraindications is good; notable omissions and a contradicted NAION RP claim reduce safety alignment.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Suggested Improvement
Clarify true contraindications for hepatic/renal impairment (no ESRD contraindication) and update NAION risk handling for RP; include grapefruit interactions and alternate therapy counseling if evidence exists in label.